WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2019> 30> 6

Volume: 30 Issue: 6

1. The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4 Page:e83—
2. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma Page:e89—
3. A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 Page:e88—
4. Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma Page:e85—
5. The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO) Page:e114—
6. Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study Page:e113—
7. A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D Page:e112—
8. Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study Page:e111—
9. Therapeutic vaccination using HPV 16 E7 to eradicate CIN3 Page:e119—
10. The Annual Meeting of the Thai Gynecologic Cancer Society 2019: Meeting report Page:e118—
11. Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy Page:e117—
12. Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer? Page:e116—
13. Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan Page:e103—
14. Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis Page:e102—
15. The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients Page:e100—
16. Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis Page:e99—
17. Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women Page:e96—
18. Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors Page:e95—
19. Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience Page:e94—
20. Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer Page:e93—
21. Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients Page:e90—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.